Jointly provided by:

Results from several key clinical trials evaluating therapeutic approaches for patients with metastatic breast cancer, metastatic castration resistant prostate cancer and non-small cell lung cancer were presented at the European Society for Medical Oncology (ESMO) 2016 Congress on October 7–11, 2016 in Copenhagen, Denmark. Participate in any of the following activities and hear leading experts in their respective fields discuss the implications for current practice and future research.

A Therapeutic Update on the Management of Patients with Breast Cancer
1.0 AMA PRA Category 1 Credit

A Therapeutic Update on Metastatic Castration Resistant Prostate Cancer
1.0 AMA PRA Category 1 Credit

A Therapeutic Update on the Management of Patients with Non-Small Cell Lung Cancer
1.0 AMA PRA Category 1 Credit

Group visibility: 
Public - accessible to all site users